ASND - Ascendis Pharma AS - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ASND is currently covered by 15 analysts with an average price target of $198.19. This is a potential upside of $55.52 (38.91%) from yesterday's end of day stock price of $142.67.

Ascendis Pharma AS's activity chart (see below) currently has 196 price targets and 208 ratings on display. The stock rating distribution of ASND is 83.7% BUY and 16.3% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.26% with an average time for these price targets to be met of 265.33 days.

Highest price target for ASND is $289, Lowest price target is $153, average price target is $194.67.

Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 18-Mar-2025. First documented stock forecast 23-Feb-2015.

Currently out of the existing stock ratings of ASND, 77 are a BUY (83.7%), 15 are a HOLD (16.3%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$200

$45.32 (29.30%)

$167

17 days ago
(18-Mar-2025)

18/22 (81.82%)

$35.35 (21.47%)

133

Buy

$200

$45.32 (29.30%)

$170

1 months 10 days ago
(25-Feb-2025)

4/18 (22.22%)

$48.47 (31.99%)

218

Buy

$260

$105.32 (68.09%)

$220

1 months 17 days ago
(18-Feb-2025)

3/9 (33.33%)

$115.92 (80.46%)

686

Buy

$194

$39.32 (25.42%)

$179

3 months 19 days ago
(16-Dec-2024)

0/4 (0%)

$57.4 (42.02%)

Buy

$153

$-1.68 (-1.09%)

$160

4 months 20 days ago
(15-Nov-2024)

6/7 (85.71%)

$26.49 (20.94%)

205

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ASND (Ascendis Pharma AS) average time for price targets to be met?

On average it took 265.33 days on average for the stock forecasts to be realized with a an average price target met ratio 44.26

Which analyst has the current highest performing score on ASND (Ascendis Pharma AS) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on ASND (Ascendis Pharma AS)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on ASND

Which analyst is the currently most bullish on ASND (Ascendis Pharma AS)?

Derek Archila with highest potential upside - $134.32

Which analyst is the currently most reserved on ASND (Ascendis Pharma AS)?

Tiago Fauth with lowest potential downside - -$65.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?